In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine
- PMID: 1656898
- PMCID: PMC1004509
- DOI: 10.1136/ard.50.9.637
In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine
Abstract
The mechanism of action of low dose methotrexate in rheumatoid arthritis has not been established. It has been shown to have an anti-inflammatory effect and to inhibit neutrophil chemotaxis, but the effect on monocytes has not been widely studied. Normal donor peripheral blood monocytes were incubated with methotrexate in vitro and their superoxide production, chemotaxis, and phagocytosis subsequently assessed. Additionally, the influence of different culture media, and of folinic acid, and the methyl donor S-adenosylmethionine, and spermidine on the methotrexate mediated effects were evaluated. It was found that methotrexate in low concentrations inhibited in vitro monocyte chemotaxis and superoxide production but only after prolonged incubation. This inhibition was augmented by incubation in medium containing a low methionine concentration and was abolished by folinic acid and S-adenosylmethionine, suggesting that methotrexate may interfere with specific methylation reactions.
Similar articles
-
The in vitro effects of methotrexate on peripheral blood mononuclear cells. Modulation by methyl donors and spermidine.Arthritis Rheum. 1990 Jul;33(7):954-9. doi: 10.1002/art.1780330706. Arthritis Rheum. 1990. PMID: 1973354
-
Folinic acid antagonizes methotrexate-induced differentiation of monocyte progenitors.Rheumatol Int. 2002 Jun;22(2):60-7. doi: 10.1007/s00296-002-0188-9. Epub 2002 Apr 20. Rheumatol Int. 2002. PMID: 12070677
-
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.Arthritis Rheum. 1989 Apr;32(4):378-85. doi: 10.1002/anr.1780320404. Arthritis Rheum. 1989. PMID: 2784965
-
Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX).Med Hypotheses. 2013 Nov;81(5):942-7. doi: 10.1016/j.mehy.2013.08.027. Epub 2013 Sep 3. Med Hypotheses. 2013. PMID: 24035689 Review.
-
Rescue after intermediate and high-dose methotrexate: background, rationale, and current practice.Pediatr Hematol Oncol. 1990;7(4):347-63. doi: 10.3109/08880019009033412. Pediatr Hematol Oncol. 1990. PMID: 2268535 Review.
Cited by
-
Low-dose methotrexate inhibits methionine S-adenosyltransferase in vitro and in vivo.Mol Med. 2012 May 9;18(1):423-32. doi: 10.2119/molmed.2011.00048. Mol Med. 2012. PMID: 22193356 Free PMC article.
-
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions.Front Pharmacol. 2021 May 28;12:680043. doi: 10.3389/fphar.2021.680043. eCollection 2021. Front Pharmacol. 2021. PMID: 34122106 Free PMC article. Review.
-
Methotrexate--how does it really work?Nat Rev Rheumatol. 2010 Mar;6(3):175-8. doi: 10.1038/nrrheum.2010.5. Nat Rev Rheumatol. 2010. PMID: 20197777 Review.
-
Mécanisme d'action du méthotrexate dans le traitement de la polyarthrite rhumatoïde.Rev Rhum Ed Fr. 2020 Mar;87(2):92-98. doi: 10.1016/j.rhum.2020.01.005. Epub 2020 Jan 11. Rev Rhum Ed Fr. 2020. PMID: 35068924 Free PMC article.
-
Methotrexate treatment of FraX fibroblasts results in FMR1 transcription but not in detectable FMR1 protein levels.J Neurodev Disord. 2013 Sep 10;5(1):23. doi: 10.1186/1866-1955-5-23. J Neurodev Disord. 2013. PMID: 24020679 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources